These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9497904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
    Castellon R, Caballero S, Hamdi HK, Atilano SR, Aoki AM, Tarnuzzer RW, Kenney MC, Grant MB, Ljubimov AV.
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
    [Abstract] [Full Text] [Related]

  • 5. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
    Suzuma K, Takagi H, Otani A, Honda Y.
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES.
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [Abstract] [Full Text] [Related]

  • 13. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
    Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM.
    Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
    Yamagishi S, Nakamura K, Matsui T, Sato T, Takeuchi M.
    Med Hypotheses; 2006 Jan; 66(5):1019-21. PubMed ID: 16188392
    [Abstract] [Full Text] [Related]

  • 18. Management of proliferative diabetic retinopathy.
    Gündüz K, Bakri SJ.
    Compr Ophthalmol Update; 2007 Jan; 8(5):245-56. PubMed ID: 18201511
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of vitronectin receptor-type integrins and osteopontin in ischemia-induced retinal neovascularization.
    Takagi H, Suzuma K, Otani A, Oh H, Koyama S, Ohashi H, Watanabe D, Ojima T, Suganami E, Honda Y.
    Jpn J Ophthalmol; 2002 Jan; 46(3):270-8. PubMed ID: 12063036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.